Posted by Michael Wonder on 23 Feb 2023
ONWARD receives new FDA breakthrough device designations for bladder control, alleviation of spasticity and blood pressure regulation after spinal cord injury
23 February 2023 - The company has now been awarded a total of eight FDA breakthrough device designations for its innovative SCI therapies.
ONWARD Medical today announced it has been granted breakthrough device designation status from the US FDA for the use of its ARC-EX platform for bladder control, alleviation of spasticity and blood pressure regulation in people with spinal cord injury.
